Correlation Between Procaps Group and Regencell Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Procaps Group and Regencell Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procaps Group and Regencell Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Procaps Group SA and Regencell Bioscience Holdings, you can compare the effects of market volatilities on Procaps Group and Regencell Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procaps Group with a short position of Regencell Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procaps Group and Regencell Bioscience.

Diversification Opportunities for Procaps Group and Regencell Bioscience

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Procaps and Regencell is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Procaps Group SA and Regencell Bioscience Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regencell Bioscience and Procaps Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procaps Group SA are associated (or correlated) with Regencell Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regencell Bioscience has no effect on the direction of Procaps Group i.e., Procaps Group and Regencell Bioscience go up and down completely randomly.

Pair Corralation between Procaps Group and Regencell Bioscience

Assuming the 90 days horizon Procaps Group SA is expected to under-perform the Regencell Bioscience. In addition to that, Procaps Group is 1.94 times more volatile than Regencell Bioscience Holdings. It trades about -0.3 of its total potential returns per unit of risk. Regencell Bioscience Holdings is currently generating about 0.02 per unit of volatility. If you would invest  610.00  in Regencell Bioscience Holdings on August 28, 2024 and sell it today you would lose (19.00) from holding Regencell Bioscience Holdings or give up 3.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy63.64%
ValuesDaily Returns

Procaps Group SA  vs.  Regencell Bioscience Holdings

 Performance 
       Timeline  
Procaps Group SA 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Procaps Group SA are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Procaps Group showed solid returns over the last few months and may actually be approaching a breakup point.
Regencell Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regencell Bioscience Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Regencell Bioscience is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Procaps Group and Regencell Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Procaps Group and Regencell Bioscience

The main advantage of trading using opposite Procaps Group and Regencell Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procaps Group position performs unexpectedly, Regencell Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regencell Bioscience will offset losses from the drop in Regencell Bioscience's long position.
The idea behind Procaps Group SA and Regencell Bioscience Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets